Taiwan 2020 Country Report     

, ,

Country Report-(Taiwan)

for the Western Pacific Pharmaceutical Forum

Executive Meeting

Taiwan, 2020

Duration      :2019/01~2019/12

Prepared byPharmaceutical Society of Taiwan

 

Section 1: Current Issues (e.g. health care policy, pharmacy law, private or government insurance benefits)
NOTE: Can all of these issues be published on WPPF Website? YES □ NO
1 In 2019, Taiwan’s National Health Insurance Agency (NHIA) offered a sum of NT$ 50 million      (US$ 1.67 million     ) to cover the pharmaceutical care services in the intensive care units (ICU). ICU pharmacists were given       the reimbursement (NT$ 220      per patient per day) after completing the SOAP form indicating the pharmacist’s interventions.
Section 2: Activities and campaigns (e.g. promotion events, campaigns)
NOTE: Can all of these issues be published on WPPF Website? □YES □ NO
1 It has become quite popular for hospitals in Taiwan to catch up with the development of           Smart and Artificial Intelligence (AI) hospitals so that they can      promote the adoption of technology in pharmacy practice, such as automated dispensing cabinet (ADC) and Robotic chemotherapy preparation.

In terms of health information system, two medical centers, Chang-Gung Memorial Hospital and China Medical University Hospital, have received the HIMSS EMRAM Level-7 international certification for electronic medical records in 2019. This HIMSS certification helped facilitate the adoption of electronic clinical decision supporting system (CDSS) in the medication management and use (MMU).

Section 3: General (e.g. change of pharmacy practice, pharmacy education, standards, quality control )
NOTE: Can all of the following issues be published on WPPF Website? □YES □ NO
1 The national project in advancing the pharmacy education(全國藥學精進計畫)developed a blueprint for the pharmacy education; pharmacy residency program, specialty pharmacists and pharmacy competency advance program in Taiwan. This national project led by all Deans of College of Pharmacy in Taiwan suggested that all hospitals should develop the specialty pharmacist program(專科藥師制度). However, since there are significant differences in terms of certification methods; core practice areas and advancement policy between hospitals, the consensus in the certification of specialty pharmacists are needed to be discussed in the near future.